The story of Sildenafil presents a complex picture for investors. While the initial introduction generated significant gains, the expiration of its intellectual property protection opened the avenue to off-brand https://socialtechnet.com/story7225082/viagra-and-the-pharmaceutical-industry-a-risky-investment